Insider trades
Harold Bernstein, CMO of Maze Therapeutics MAZE, has filed 0 purchases and 21 sales on the open market. Over the past 12 months that comes to a net sale of $7.6M. The latest trade was on 10/01.
Harold Bernstein
President, R&D & CMO
- Company
- Maze Therapeutics MAZE
- First filing
- 25/09/24
- Trades
- 46 trades
- Buys / sales
- 0 / 21
- 12-month net buying
- −$7.6M
- Last trade
- 10/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 10/01 | 10/02 | 16,141 sh | $26.93 | $434,743.31 | −100.0% | |
MAZE | Open-market sale10b5-1 plan | 06/01 | 06/03 | 14,853 sh2 trades | $25.66avg. | $381,055.21 | −100.0% |
| Open-market sale10b5-1 plan | 05/14 | 05/18 | 15,000 sh | $26.22 | $393,300 | −100.0% | |
MAZE | Open-market sale10b5-1 plan | 04/01 | 04/02 | 15,000 sh3 trades | $29.46avg. | $441,894.36 | −100.0% |
MAZE | Open-market sale10b5-1 plan | 03/20 | 03/20 | 15,000 sh3 trades | $49.10avg. | $736,430.48 | −100.0% |
MAZE | Open-market sale10b5-1 plan | 03/10 | 03/12 | 30,000 sh2 trades | $50.46avg. | $1,513,698.36 | −100.0% |
MAZE | Open-market sale10b5-1 plan | 02/02 | 02/04 | 15,000 sh4 trades | $46.02avg. | $690,325.28 | −100.0% |
| Open-market sale10b5-1 plan | 01/07 | 01/09 | 25,156 sh | $40.20 | $1,011,271.2 | −100.0% | |
MAZE | Open-market sale10b5-1 plan | 01/02–01/05 | 01/06 | 4,844 sh2 trades | $40.39avg. | $195,665.76 | −100.0% |
MAZE | Open-market sale10b5-1 plan | 25/12/29 | 25/12/31 | 45,000 sh2 trades | $40.57avg. | $1,825,448 | −100.0% |